This Article Full Text Full Text (PDF) All Versions of this Article: 35/11/2592    most recent 01.STR.0000144646.96121.d2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schmidt, H. Articles by van Duijn, C. Search for Related Content PubMed PubMed Citation Articles by Schmidt, H. Articles by van Duijn, C. Related Collections ACE/Angiotension receptors Genetics of Stroke

(Stroke. 2004;35:2592.)
© 2004 American Heart Association, Inc.

Original Contributions

Angiotensinogen Promoter B-Haplotype Associated With Cerebral Small Vessel Disease Enhances Basal Transcriptional Activity

Helena Schmidt, MD MSc; Yurii S. Aulchenko, PhD; Natascha Schweighofer, MSc; Reinhold Schmidt, MD; Sasa Frank, PhD; Gerhard M. Kostner, PhD; Erwin Ott, MD Cornelia van Duijn, MD

From the Institute of Medical Molecular Biology and Biochemistry (H.S., N.S., S.F., G.M.K.), and the Department of Neurology (R.S., E.O.), Medical University of Graz, Austria; and the Genetic Epidemiology Unit (Y.S.A., C.v.D.), Erasmus University, Rotterdam, the Netherlands.

Correspondence to Dr Helena Schmidt, Institute of Medical Molecular Biology and Biochemistry, Medical University of Graz, Harrachgasse 21, 8010 Graz, Austria. E-mail helena.schmidt{at}uni-graz.at

Background and Purpose— Previously, we described the presence of 5 haplotypes (A to E) at the angiotensinogen (AGT) promoter and reported a significant association between the B-haplotype (nucleotide substitutions –6:GA and –20:AC compared with the wild-type A-haplotype) and magnetic resonance imaging correlates of cerebral small vessel disease (cSVD). The association was independent of hypertension, suggesting a brain-specific effect of this haplotype. In the current study, we investigated transcriptional activities of the 5 promoter haplotypes in astrocytes, the main source of cerebral AGT, and in hepatocytes, the main source of systemic AGT, as well as determined the evolutionary relatedness of the promoter haplotypes.

Methods— Transcriptional activity depending on the haplotypes and the –6:A and –20:C substitutions was measured in transiently transfected A172 and HepG2 cells. We genotyped 5 new single nucleotide polymorphisms (SNPs) at the AGT gene and measured linkage disequilibrium (LD) among SNPs and the promoter haplotypes. An evolution-based haplotype tree was constructed.

Results— The B-haplotype increased transcriptional activity in both cell types. Its effect was stronger in astrocytes than in hepatocytes (2.4±0.09-fold, P<0.001 versus 1.6±0.06-fold, P=0.014). Importantly, in astrocytes the combination of the –6:A and the –20:C was mandatory for increased activity, whereas in hepatocytes the –20:C on its own was sufficient. Strong LD between the 5 new SNPs and the promoter haplotypes allowed the reconstruction of 9 haplotypes over the AGT gene. Cladistic analyses suggest that the B-haplotype represents an ancient promoter variant.

Conclusions— Combination of the –6:A and –20:C substitutions in the B-haplotype may promote the development of cSVD by enhancing cerebral angiotensinogen expression.

Key Words: angiotensinogen • gene expression regulation • genetics • white matter

This article has been cited by other articles:

				M J E van Rijn, M J Bos, A Isaacs, M Yazdanpanah, A Arias-Vasquez, B H C. Stricker, O H Klungel, B A Oostra, P J Koudstaal, J C Witteman, et al. Polymorphisms of the renin angiotensin system are associated with blood pressure, atherosclerosis and cerebral white matter pathology J. Neurol. Neurosurg. Psychiatry, October 1, 2007; 78(10): 1083 - 1087. [Abstract] [Full Text] [PDF]

				M. E. Dickson, M. B. Zimmerman, K. Rahmouni, and C. D. Sigmund The -20 and -217 Promoter Variants Dominate Differential Angiotensinogen Haplotype Regulation in Angiotensinogen-Expressing Cells Hypertension, March 1, 2007; 49(3): 631 - 639. [Abstract] [Full Text] [PDF]

				M. E. Dickson and C. D. Sigmund Genetic Basis of Hypertension: Revisiting Angiotensinogen Hypertension, July 1, 2006; 48(1): 14 - 20. [Full Text] [PDF]